Zysk Z Działalności Operacyjnej Zmiana Data
Alaunos Therapeutics USD -1.19M 148K 2025-09
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 7.11B 4.14B 2026-03
Baxter International USD -214.2M 415.4M 2025-12
Biogen USD 514.3M 128.8M 2026-03
Bioline Rx USD -2.21M 96K 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Curis USD -7.88M 4.63M 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Incyte USD 383.88M 47.43M 2025-12
Intrexon USD -60.84M 26.62M 2024-06
Ionis Pharmaceuticals USD -118M 97M 2026-03
J&J USD 6.62B 1.03B 2026-03
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Merck USD 6.24B 318M 2025-12
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Novartis USD 4.24B 171M 2026-03
Organigram Holdings CAD -20.13M 7.92M 2025-12
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pfizer USD 4.65B 3.99B 2025-12
Pharma Mar EUR 43.61M 47.57M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Qiagen NV USD 121.88M 15.41M 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sartorius EUR 160.7M 9.5M 2026-03
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
TG Therapeutics USD 50.49M 21.13M 2025-12
Tilray USD -20.01M 9.34M 2025-09
Verastem USD -41.48M 23.2M 2025-12
Zealand Pharma A/S -707.05M 245.73M 2025-12
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03